In the BioHarmony Drug Report Database

"Preview" Icon

Oxaliplatin

Eloxatin, Oxaliplatin (oxaliplatin) is a small molecule pharmaceutical. Oxaliplatin was first approved as Eloxatin on 2002-08-09. It is used to treat colorectal neoplasms, ovarian neoplasms, testicular neoplasms, and urinary bladder neoplasms in the USA.

 

Trade Name

 

Eloxatin, Oxaliplatin
 

Common Name

 

oxaliplatin
 

ChEMBL ID

 

CHEMBL414804
 

Indication

 

colorectal neoplasms, ovarian neoplasms, testicular neoplasms, urinary bladder neoplasms
 

Drug Class

 

Antineoplastics (platinum derivatives)

Image (chem structure or protein)

Oxaliplatin structure rendering